BioCentury | Oct 1, 2015
Translation in Brief

Net worth

One of the byproducts of large-scale screening programs is the wealth of data left on the cutting room floor that aren't analyzed beyond the studies' original aims. A group of systems biologists has developed a...
BioCentury | Dec 3, 2012
Company News

Immunetics management update

Immunetics Inc. , Boston, Mass. Business: Diagnostic, Infectious Hired: John Yonkin as CEO and a director, formerly VP of strategic projects at Alere Inc. ; he succeeds Andrew Levin, who remains president WIR Staff Diagnostic Infectious...
Items per page:
1 - 2 of 2
BioCentury | Oct 1, 2015
Translation in Brief

Net worth

One of the byproducts of large-scale screening programs is the wealth of data left on the cutting room floor that aren't analyzed beyond the studies' original aims. A group of systems biologists has developed a...
BioCentury | Dec 3, 2012
Company News

Immunetics management update

Immunetics Inc. , Boston, Mass. Business: Diagnostic, Infectious Hired: John Yonkin as CEO and a director, formerly VP of strategic projects at Alere Inc. ; he succeeds Andrew Levin, who remains president WIR Staff Diagnostic Infectious...
Items per page:
1 - 2 of 2